Mine Cicek, Ph.D.

Location

Contact

SUMMARY

Mine S. Cicek, Ph.D., is a molecular cancer genetic epidemiologist. For more than a decade, her research has focused on cancer susceptibility genes for prostate, colon and ovarian cancers.

Dr. Cicek is the director of the Biospecimens Accessioning and Processing (BAP) core laboratory on the Mayo Clinic campus in Rochester, Minnesota. She contributes her expertise to research studies and clinical trials overseeing biospecimen collections, processing and storage. She continuously brings new knowledge and technology to her lab to improve best practices for biospecimens usage.

Focus areas

• Biorepository Program. This program serves the needs of the Mayo research community for high-quality, clinically annotated biospecimens and provides access to two centralized core laboratories. Dr. Cicek's lab is one of the core laboratories that provides services for the collection, processing, storage, distribution and management of biospecimens.
• Cancer research. Dr. Cicek's laboratory supports cancer research studies providing numerous valuable services and resources, including access to cutting-edge technology and methodology, scientific consultation, reliability, cost-effectiveness and quality control. Her laboratory is one of the Mayo Clinic Comprehensive Cancer Center shared resources.
• Alliance. The National Cancer Institute's (NCI) National Clinical Trial Network (NCTN) Alliance for Clinical Trials in Oncology (Alliance) represents NCI-funded cancer cooperative groups, including the American College of Surgeons Oncology Group (ACOSOG); Cancer and Leukemia Group B (CALGB); and the North Central Cancer Treatment Group (NCCTG). Dr. Cicek's laboratory is a part of the Alliance Biorepository and Biospecimen Resource (ABBR), and supports clinical cancer trials with respect to biospecimen procurement, tracking, processing, quality assurance, storage and distribution.
• ACCRU. The Academic and Community Cancer Research United (ACCRU) is a clinical research group network of more than 60 academic and community-based cancer treatment clinics and hospitals in the United States and Canada. Dr. Cicek's laboratory provides a full range of biospecimens services for ACCRU to manage the translational component of clinical research conducted in clinical trials to improve cancer care.